NCT07731152

Brief Summary

This prospective comparative study aims to evaluate the outcomes of septoplasty with or without inferior turbinate reduction in patients with symptomatic deviated nasal septum. Subjective and objective outcomes will be assessed using the NOSE score, Peak Nasal Inspiratory Flow (PNIF), and nasal endoscopic examination before and after surgery.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
12mo left

Started Sep 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 23, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 28, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

July 28, 2026

Status Verified

July 1, 2026

Enrollment Period

1 year

First QC Date

July 23, 2026

Last Update Submit

July 23, 2026

Conditions

Keywords

septoplastydeviated nasal septumnasal obstructioninferior turbinate hypertrophynose scorepeak nasal inspiratory flowmeter (PNIF)endoscopic assessment

Outcome Measures

Primary Outcomes (1)

  • Improvement in nasal obstruction symptoms

    Assessment of improvement in nasal obstruction symptoms after surgery using the Nasal Obstruction Symptom Evaluation (NOSE) score.

    Baseline (preoperative), 1 month postoperative, and 3 months postoperative

Secondary Outcomes (3)

  • Change in NOSE score

    Baseline, 1 month postoperative, and 3 months postoperative

  • Change in Peak Nasal Inspiratory Flow (PNIF)

    Baseline, 1 month postoperative, and 3 months postoperative

  • Endoscopic nasal examination findings

    Baseline, 1 month postoperative, and 3 months postoperative

Study Arms (2)

septoplasty alone

ACTIVE COMPARATOR

Patients will undergo septoplasty alone for correction of symptomatic deviated nasal septum. Postoperative outcomes will be assessed using NOSE score, Peak Nasal Inspiratory Flow (PNIF), and endoscopic examination.

Procedure: septoplasty

septoplasty with inferior turbinate reduction

ACTIVE COMPARATOR

Patients will undergo septoplasty combined with inferior turbinate reduction for correction of symptomatic deviated nasal septum with associated inferior turbinate hypertrophy. Postoperative outcomes will be assessed using NOSE score, Peak Nasal Inspiratory Flow (PNIF), and endoscopic examination.

Procedure: septoplasty with inferior turbinate reduction.

Interventions

septoplastyPROCEDURE

Surgical correction of deviated nasal septum to relieve nasal obstruction.

septoplasty alone

Surgical correction of deviated nasal septum combined with inferior turbinate reduction to improve nasal airflow and relieve obstruction.

septoplasty with inferior turbinate reduction

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with symptomatic deviated nasal septum causing persistent nasal obstruction, aged 18-50 years, who failed medical treatment for at least 3 months, will be included in the study.

You may not qualify if:

  • Patients with previous nasal surgery, nasal polyposis, chronic rhinosinusitis, alar collapse, uncontrolled allergic rhinitis, nasal tumors, or external nasal deformity requiring rhinoplasty will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Fokkens WJ, Lund VJ, Hopkins C, et al. EPOS 2020: European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology Supplement. 2020.

    BACKGROUND
  • Han JK, Stringer SP, Rosenfeld RM, Archer SM, Baker DP, Brown SM, Edelstein DR, Gray ST, Lian TS, Ross EJ, Seiden AM, Setzen M, Tollefson TT, Ward PD, Welch KC, Wise SK, Nnacheta LC. Clinical Consensus Statement: Septoplasty with or without Inferior Turbinate Reduction. Otolaryngol Head Neck Surg. 2015 Nov;153(5):708-20. doi: 10.1177/0194599815606435.

    PMID: 26527752BACKGROUND
  • Stewart MG, Smith TL, Weaver EM, Witsell DL, Yueh B, Hannley MT, Johnson JT. Outcomes after nasal septoplasty: results from the Nasal Obstruction Septoplasty Effectiveness (NOSE) study. Otolaryngol Head Neck Surg. 2004 Mar;130(3):283-90. doi: 10.1016/j.otohns.2003.12.004.

    PMID: 15054368BACKGROUND

MeSH Terms

Conditions

Nasal Obstruction

Condition Hierarchy (Ancestors)

Nose DiseasesRespiratory Tract DiseasesAirway ObstructionRespiratory InsufficiencyRespiration DisordersOtorhinolaryngologic Diseases

Study Officials

  • Osama Mohammed Rashad, professor

    Department of otolaryngology, faculty of medicine, sohag university

    PRINCIPAL INVESTIGATOR
  • khaled Gamal Dahy, assistant professor

    Department of otolaryngology, faculty of medicine, sohag university

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mena Mikhael, M.B.B.Ch

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
No masking will be applied. Both participants and investigators will be aware of the surgical intervention performed.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be assigned into two parallel groups: Group A will undergo septoplasty alone, and Group B will undergo septoplasty with inferior turbinate reduction. Postoperative outcomes will be compared between the two groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Mena Mikhael Roshdy

Study Record Dates

First Submitted

July 23, 2026

First Posted

July 28, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

July 28, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share